Motley Fool Staff

The chipmaker's business practices are now under the legal microscope -- again.

Two hedge funds have the e-commerce company in their sights.

Over the past few years of entertainment industry evolution, the cable major has basically been treading water.

The government shutdown pushed millions of Americans households into the red.

If the past month’s troubles in Washington have shown folks anything, it’s that living without a financial cushion can get painful really quick.

The government shutdown left millions of Americans scrambling to keep their households afloat.

Yes, the earnings report was better than expected. But investors are grading the company on an awfully generous curve.

Jack Bogle could easily have become a billionaire. Instead, he changed the investing game forever.

It’s an honor just to be nominated (and a good harbinger of profits, too).

And what are the big names that remain optimistic doing right?

The aluminum-parts maker had what looked like a viable bid from Apollo Global Management.

Nobody can say its electric cars are not impressive in most ways. But...

Find out how CROs profit from the biotech boom no matter what happens in the clinic.

These biotech suppliers have performed extremely well for investors. Here's why each of them is poised for prosperity.

Biotech ETFs have a great track record of creating shareholder value and can be a smart choice for healthcare-focused investors.

The inventor of the index fund didn't just give people a new way to invest. He allowed us all to call out the whole fee-generating machinery of active management.

One is the undisputed leader in its industry. Another has been paying a dividend consistently for over a century.

Sure, fourth-quarter subscriber gains weren’t quite as good as expected, but that price hike will do good things to revenues and profits.

It’s entering the market in a big way, and it has some major shows coming up.

That’s certainly not the case with its box-office slate.